Patent expiry and biosimilars: difference between revisions
Diff·revision 12 → 13·04:42, 25 May 2025
Difference between revision 12 and revision 13 of Patent expiry and biosimilars. This revision changed no lines of source — the edit was a null or whitespace change.
| Revision 12 — 12:30, 11 May 2025 StyleSheetSybil (talk) rm the speculation about future scheduling 3,580 bytes ±0 | Revision 13 — 04:42, 25 May 2025 FiveOhThreeB (talk) clarify that a business licence is not a manufacturing authorisation 3,580 bytes ±0 | ||
|---|---|---|---|
| — | No change to the page source. | — |